GOP Rep. Collins’ son and son’s fiancee bought stock days before getting tip on drug trial, SEC says

Chris Collins' son Cameron Collins and his fiancee Lauren Zarsky bought Innate Immunotherapeutics stock in 2017 allegedly because they believed — mistakenly — that the company's multiple sclerosis treatment would yield positive results, the SEC says.